Odihale 50 Inhaler 120 MDI

Odihale 50 Inhaler 120 MDI belongs to the class of medicines called respiratory stimulants. It treats asthma and chronic obstructive pulmonary diseases (COPD). Asthma is a severe long-term health condition occurring due to the narrowing and swelling of the bronchial airways in the lungs, thus causing difficulty in breathing. Symptoms may include shortness of breath or wheezing (whistling sound while breathing). COPD is a group of long-term lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes) causing restricted airways. Odihale 50 Inhaler 120 MDI helps reduce symptoms of asthma and COPD.

Odihale 50 Inhaler 120 MDI contains Fluticasone Furoate (an inhaled corticosteroid) and Vilanterol (long-acting beta-agonists—LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate inhibits the release of certain chemicals in the body that cause inflammatory reactions, thus providing relief from sneezing, shortness of breath, or wheezing.

Odihale 50 Inhaler 120 MDI is for inhalation use only. It should be used as your doctor advises. Your doctor will recommend the dose and duration of medicine based on your condition. Odihale 50 Inhaler 120 MDI may cause specific side effects such as sore throat, sneezing, headache, cough, low fever, chest tightness, stuffy nose, a fungal infection in the mouth, nausea, stomach upset, dizziness, nervousness, or vomiting. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Odihale 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. This medicine should be avoided in patients with life-threatening conditions of asthma or COPD. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, or kidney/liver problems or take any immunosuppressant medicines before taking this medicine. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Odihale 50 Inhaler 120 MDI. If you experience severe difficulty breathing or wheezing while using Odihale 50 Inhaler 120 MDI, please consult your doctor immediately so that alternative medicine may be prescribed. Odihale 50 Inhaler 120 MDI is not recommended for children below 12 years of age.

Odihale 50 Inhaler 120 MDI is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). The detailed uses of Odihale 50 Inhaler 120 MDI are as follows:

• Asthma Management: Odihale 50 Inhaler 120 MDI controls and prevents symptoms of asthma, such as wheezing and shortness of breath, by reducing inflammation and improving lung function.
• Chronic Obstructive Pulmonary Disease (COPD) Treatment: Odihale 50 Inhaler 120 MDI manages COPD symptoms, including chronic bronchitis and emphysema, by improving airflow obstruction and reducing exacerbations, ultimately enhancing lung function and quality of life.

• Follow your doctor’s instructions on the dosage and duration of treatment.
• Check the label for directions and use it as advised by the doctor. Inhale Odihale 50 Inhaler 120 MDI by placing the mouthpiece of the inhaler in your mouth and breathing in deeply.
• After using the inhaler, rinse your mouth with water and spit out.

Odihale 50 Inhaler 120 MDI is a combination medicine that contains Fluticasone Furoate (inhaled corticosteroid) and Vilanterol (LABA). Vilanterol belongs to the class of bronchodilators that works by relaxing muscles and opening the airways of the lungs. Fluticasone Furoate works by inhibiting the release of certain chemicals in the body that cause inflammatory reactions. Odihale 50 Inhaler 120 MDI also helps reduce exacerbations in patients suffering from COPD.

Odihale 50 Inhaler 120 MDI should be avoided if you are allergic to any of its components. Inform your doctor if you have any other lung infections, glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, kidney/liver disease, or if you are taking any immunosuppressant medicines, as it can lead to serious infections. Regular monitoring of potassium levels and blood sugar levels is recommended while taking Odihale 50 Inhaler 120 MDI. If you are pregnant or breastfeeding, inform your doctor before starting treatment with Odihale 50 Inhaler 120 MDI. Sometimes, this medicine may worsen asthma symptoms in some patients. If you experience severe difficulty in breathing or wheezing, please consult a doctor immediately so that alternative medicine may be prescribed. Odihale 50 Inhaler 120 MDI is not recommended for children below 12 years of age.